1. Home
  2. Research
  3. Research Groups
  4. Translational Haematology

Translational Haematology

Our Translational Hematology group was created with the aim of generating knowledge in the field of hematology and collaborating with other groups for the implementation of projects. Our activity is based on a broad portfolio of clinical trials, basic research projects and registry studies. The area of ​​knowledge in which we focus is the study of the immune system and its relationship with oncohematological diseases and their infectious complications, cell therapy, study of the adverse effects of drugs and optimization in obtaining and using blood components in Transfusion Therapy.

Search for publications

Only original articles, editorials, guidelines.

  • Garcia-Casanovas A, Bisbe E, Garcia-Altes A, Vizoso A, Duran-Jorda X, Sanchez-Pedrosa G, Barquero M, Colomina MJ, Basora M.

    Hospital variation in quality indicators for patient blood management in total knee and hip arthroplasty: a retrospective cohort study.

    BRITISH JOURNAL OF ANAESTHESIA . 133(3): 637-646. Number of citations: 12

    [doi:10.1016/j.bja.2024.05.019]

  • Simoes C, Gonzalez C, Vergez F, Sarry A, Bertoli S, Ariceta B, Martínez-Cuadrón D, Bergua JM, Vives S, Algarra L, Tormo M, Martinez P, Serrano J, Herrera P, Ramos F, Salamero O, Lavilla E, Gil C, Lopez-Lorenzo JL, Vidriales MB, Chillon C, Labrador J, Falantes JF, Sayas MJ, Ayala R, Martinez-Lopez J, Villar S, Calasanz MJ, Prosper F, San-Miguel JF, Sanz MÁ, Récher C, Paiva B, Montesinos P.

    Data-driven flow cytometry classification of blast differentiation in older patients with acute myeloid leukemia.

    Blood Neoplasia . 1(3): 100027-100027.

    [doi:10.1016/j.bneo.2024.100027]

  • Mingot-Castellano ME, Reguera-Ortega JL, Zafra Torres D, Hernani R, Lopez-Godino O, Guerreiro M, Herrero B, López-Corral L, Luna A, Gonzalez-Pinedo L, Chinea-Rodriguez A, Africa-Martín A, Bailen R, Martinez-Cibrian N, Balsalobre P, Filaferro S, Alonso-Saladrigues A, Barba P, Perez-Martinez A, Calbacho M, Perez-Simón JA, Sánchez-Pina JM, On Behalf Of The Spanish Group Of Hematopoietic Transplant And Cell Therapy Get.

    Use of Eltrombopag to Improve Thrombocytopenia and Tranfusion Requirement in Anti-CD19 CAR-T Cell-Treated Patients.

    Journal of Clinical Medicine . 13(17): . Number of citations: 4

    [doi:10.3390/jcm13175117]

  • Sánchez-Menéndez C, de la Calle-Jiménez O, Mateos E, Vigón L, Fuertes D, Murciano Antón MA, San José E, García-Gutiérrez V, Cervero M, Torres M, Coiras M.

    Different polarization and functionality of CD4+ T helper subsets in people with post-COVID condition.

    Frontiers in Immunology . 15: 1431411-1431411. Number of citations: 3

    [doi:10.3389/fimmu.2024.1431411]

  • García-Gutiérrez V, Gómez-Casares MT, Xicoy B, Casado-Montero F, Orti G, Giraldo P, Hernández-Boluda JC.

    Critical review of clinical data and expert-based recommendations for the use of bosutinib in the treatment of chronic myeloid leukemia.

    Frontiers in Oncology . 14: 1405467-1405467. Number of citations: 2

    [doi:10.3389/fonc.2024.1405467]

  • Zelenetz AD, Jurczak W, Ribrag V, Linton K, Collins GP, Jiménez JL, Bishton M, Dholaria B, Mengarelli A, Phillips TJ, Sungala N, Musuraca G, Sheehy O, Van Den Neste E, Odera M, Miao L, Gold DP, Ghalie RG, Zinzani PL.

    The PI3Kd inhibitor zandelisib on intermittent dosing in relapsed/refractory follicular lymphoma: Results from a global phase 2 study.

    HemaSphere . 8(8): . Number of citations: 5

    [doi:10.1002/hem3.138]

  • Kiladjian JJ, Marin FF, Al-Ali HK, Alvarez-Larrán A, Beggiato E, Bieniaszewska M, Breccia M, Buxhofer-Ausch V, Cerna O, Crisan AM, Danaila CD, De Stefano V, Döhner K, Empson V, Gora-Tybor J, Griesshammer M, Grosicki S, Guglielmelli P, García-Gutierrez V, Heidel FH, Illés A, Tomuleasa C, James C, Koschmieder S, Krauth MT, Krejcy K, Lazaroiu MC, Mayer J, Nagy ZG, Nicolini FE, Palandri F, Pappa V, Reiter AJ, Sacha T, Schlager S, Schmidt S, Terpos E, Unger M, Wölfler A, Cirici BX, Klade C.

    ROP-ET: a prospective phase III trial investigating the efficacy and safety of ropeginterferon alfa-2b in essential thrombocythemia patients with limited treatment options.

    ANNALS OF HEMATOLOGY . 103(7): 2299-2310. Number of citations: 17

    [doi:10.1007/s00277-024-05665-4]

  • Piñana JL, Vazquez L, Heras I, Aiello TF, López-Corral L, Arroyo I, Soler-Espejo E, García-Cadenas I, Garcia-Gutierrez V, Aroca C, Chorao P, Olave MT, Lopez-Jimenez J, Gómez MA, Arellano E, Cuesta-Casas M, Avendaño-Pita A, González-Santillana C, Hernández-Rivas JÁ, Roldán-Pérez A, Mico-Cerdá M, Guerreiro M, Morell J, Rodriguez-Galvez P, Labrador J, Campos D, Cedillo Á, Vidal CG, Martino R, Solano C.

    Omicron SARS-CoV-2 infection management and outcomes in patients with hematologic disease and recipients of cell therapy.

    Frontiers in Oncology . 14: 1389345-1389345. Number of citations: 9

    [doi:10.3389/fonc.2024.1389345]

  • Kwon M, Gómez-Centurión I, Oarbeascoa G, Torres M, Martinez AP, Suarez-Lledó M, Chinea A, Cascón MJP, Vazquez L, Espigado I, Izquierdo I, Parody R, Cadenas IG, Calbacho M, Sierra PG, Heras I, Yañez L, Torrent A, Bautista G, Gonzalez S, Roldan E, Vallejo JC, Bailen R, Borrero A, Lopez-Jiménez J, Casas MAC, Solano C.

    Real-World Experience with Isavuconazole in Allogeneic Stem Cell Transplantation in Spain.

    Transplantation and Cellular Therapy . 30(10): 10331-10338. Number of citations: 2

    [doi:10.1016/j.jtct.2024.06.009]

  • Gómez-Centurión I, Gallardo Morillo AI, Pérez Martínez A, Cabrero Calvo M, Chinea A, González L, Pedraza A, Jiménez Lorenzo MJ, Robles MC, Bailén R, Cascón MJP, Cabero A, Piñana Sánchez JL, Luna A, Perera Alvarez M, Rovira M, Torrent Catarineu A, Sánchez-Pina J, Kwon M.

    Sinusoidal Obstruction Syndrome/Veno-Occlusive Disease after Unmanipulated Haploidentical Hematopoietic Stem Cell Transplantation with Post-Transplantation Cyclophosphamide: A Study on Behalf of the Spanish Hematopoietic Stem Cell Transplantation and Cellular Therapy Group (GETH).

    Transplantation and Cellular Therapy . 30(9): 1-8. Number of citations: 8

    [doi:10.1016/j.jtct.2024.06.003]

  • Gonzalez-Lopez TJ, Bermejo N, Cardesa-Cabrera R, Martínez V, Aguilar-Monserrate G, Pérez Segura G, García AD, Luis-Navarro J, Lakhwani S, Acedo N, Lozano ML, Bernat S, Torres-Tienza A, Ruano A, Jarque I, Galán Alvarez P, Benet Campos C, Marcellini-Antonio S, Jimenez-Bárcenas R, Martínez-Carballeira D, de Miguel Llorente D, Perona Blázquez Á, González-Gascón-Y-Marín I, Lopez-Ansoar E, Alonso Alonso JM, Bengochea-Casado ML, Díaz Gálvez FJ, Moretó A, Moreno G, Hernández-Martin R, de Cabo E, Davila-Valls J, Cuesta A, Pastoriza Cruz C, Hermida G, García C, Pozas-Mañas MA, Aguilar-Franco C, Fernandez-Jimenez D, Navas-Elorza B, López-Santamaría Castro C, Lorenzo Vizcaya A, Ortín X, Pintos MG, Piernas S, Díaz-Santa J, Soto-Ortega I Dr, Provan D, García-Donas Gabaldón G.

    Fostamatinib effectiveness and safety for immune thrombocytopenia in clinical practice.

    BLOOD . 144(6): 646-656. Number of citations: 39

    [doi:10.1182/blood.2024024250]

  • Labrador J, Martínez-Cuadrón D, Boluda B, Serrano J, Gil C, Pérez-Simón JA, Bernal T, Bergua JM, Martínez-López J, Rodríguez-Medina C, Vidriales MB, García-Boyero R, Algarra L, Polo M, Sayas MJ, Tormo M, Alonso-Domínguez JM, Herrera P, Lavilla E, Ramos F, Amigo ML, Vives-Polo S, Rodríguez-Macías G, Mena-Durán A, Pérez-Encinas MM, Arce-Fernández O, Cuello R, Sánchez-García J, Gómez-Casares MT, Chillón MC, Calasanz MJ, Ayala R, Rodriguez-Veiga R, Barragán E, Montesinos P.

    Evolving patterns and clinical outcome of genetic studies performed at diagnosis in acute myeloid leukemia patients: Real life data from the PETHEMA Registry.

    CANCER . 130(20): 3436-3451. Number of citations: 4

    [doi:10.1002/cncr.35431]

  • Fernández-Miranda I, Pedrosa L, González-Rincón J, Espinet B, de la Cruz Vicente F, Climent F, Gómez S, Royuela A, Camacho FI, Martín-Acosta P, Yanguas-Casás N, Domínguez M, Méndez M, Colomo L, Salar A, Horcajo B, Navarro M, García-Cosío M, Piris-Villaespesa M, Llanos M, García JF, Sequero S, Mercadal S, García-Hernández S, Navarro B, Mollejo M, Provencio M, Sánchez-Beato M.

    Generation and External Validation of a Histologic Transformation Risk Model for Patients with Follicular Lymphoma.

    MODERN PATHOLOGY . 37(7): 100516-100516. Number of citations: 5

    [doi:10.1016/j.modpat.2024.100516]

  • Mingot-Castellano ME, García-Candel F, Nieto JM, García-Arroba Peinado J, de la Rubia Comos J, Gomez-Segui I, Paciello-Coronel ML, Valcarcel D, Jiménez M, Cid J, Lozano M, García-Gala JM, Angós-Vazquez S, Vara Pampliega M, Guerra Dominguez L, Ávila-Idrovo LF, Oliva Hernandez A, Zalba S, Tallón Ruiz I, Ortega Sánchez S, Goterris R, Moreno Jimenez MG, Domínguez-Acosta L, Araiz-Ramírez M, Hernández-Mateo LM, Flores Ballester E, Del Rio-Garma J, Pascual Izquierdo C.

    ADAMTS13 RECOVERY IN ACUTE THROMBOTIC THROMBOCYTOPENIC PURPURA AFTER CAPLACIZUMAB THERAPY. THE SPANISH REGISTRY.

    BLOOD . 143(18): 1807-1815. Number of citations: 18

    [doi:10.1182/blood.2023022725]

  • Núñez-Torrón Stock C, Jiménez Chillón C, Martín Moro F, Marquet Palomanes J, Piris Villaespesa M, Roldán Santiago E, Rodríguez Martín E, Chinea Rodríguez A, García Gutiérrez V, Moreno Jiménez G, López Jiménez J, Herrera Puente P.

    Survival after allogeneic transplantation according to pretransplant minimal residual disease and conditioning intensity in patients with acute myeloid leukemia.

    Frontiers in Oncology . 14: 1394648-1394648. Number of citations: 4

    [doi:10.3389/fonc.2024.1394648]

  • Meijon-Ortigueira MDM, Alvarez-Roman MT, De La Corte H, Butta N, Jimenez-Yuste V.

    Predicting joint involvement through tailored prophylaxis in severe haemophilia A, is it possible?

    HAEMOPHILIA . 30(3): 678-684. Number of citations: 1

    [doi:10.1111/hae.15014]

  • Medina-Herrera A, Vazquez I, Cuenca I, Rosa-Rosa JM, Ariceta B, Jimenez C, Fernandez-Mercado M, Larrayoz MJ, Gutierrez NC, Fernandez-Guijarro M, Gonzalez-Calle V, Rodriguez-Otero P, Oriol A, Rosiñol L, Alegre A, Escalante F, De La Rubia J, Teruel AI, De Arriba F, Hernandez MT, Lopez-Jimenez J, Ocio EM, Puig N, Paiva B, Lahuerta JJ, Bladé J, San Miguel JF, Mateos MV, Martinez-Lopez J, Calasanz MJ, Garcia-Sanz R.

    The genomic profiling of high-risk smoldering myeloma patients treated with an intensive strategy unveils potential markers of resistance and progression.

    Blood Cancer Journal . 14(1): 74-74. Number of citations: 12

    [doi:10.1038/s41408-024-01053-3]

  • Ríos-Tamayo R, Lecumberri R, Cibeira MT, González-Calle V, Alonso R, Domingo-González A, Landete E, Encinas C, Iñigo B, Blanchard MJ, Alejo E, Krsnik I, Gómez-Bueno M, Garcia-Pavia P, Segovia-Cubero J, Rosiñol L, Lahuerta JJ, Martínez-López J, Bladé J.

    A Simple Frailty Score Predicts Survival and Early Mortality in Systemic AL Amyloidosis.

    Cancers . 16(9): . Number of citations: 11

    [doi:10.3390/cancers16091689]